998 / 1024
The “model-based” approach
Multivariable Normal Tissue Complication
Probability (NTCP) models
In silico planning comparative studies
Comparison of dose distributions
Estimation of the potential benefit
integrating step 1 and 2
Selection
Validation
Clinical validation:
(RCT’s)
Model-based validation studies
Langendijk R&O 2013